Thomas Clozel, Owkin | What does AI Biotech really mean | E10 episode artwork

EPISODE · Dec 18, 2023 · 1H 20M

Thomas Clozel, Owkin | What does AI Biotech really mean | E10

from Flot.bio x Philip Hemme · host Flot.bio

In an online special, we’re interviewing Thomas Clozal, the co-founder and CEO of Owkin. We talk about scaling AI in biotech and how it feels to be the child of billionaire biotech parents.💎 ABOUT THE SPEAKERThomas founded Owkin in 2016 and I first met him in 2017. At that time, Owkin was still a baby and I wasn’t sure where it would go. Now it’s a unicorn following a $180M investment from Sanofi in 2021 and has over 300 employees. 🔗 LINKS MENTIONED - Exscientia Expands Biologics Design Capability with Automated Laboratory https://investors.exscientia.ai/press-releases/press-release-details/2022/Exscientia-Expands-Biologics-Design-Capability-with-Automated-Laboratory/default.aspx- Marc de Garidel, Abivax | How to make two billion 💶 exits (kind of smoothly) | E09 https://youtu.be/njZR8udGBTQ- How AI Can Tackle Cancer - Leader in Innovation (Fast Company) https://open.spotify.com/episode/2LQGtAaD7ALSsHslNZJ1mC?si=96a0ba9ddafd4fbc- Aviv Regev leads Genentech's next revolution with AI - https://endpts.com/aviv-regev-leads-genentechs-next-revolution-with-ai/- The 25 Most Valuable Biotech Companies in Europe in 2025: https://flot.bio/most-valuable-biotech-companies-europe-2025/ 📜 TRANSCRIPTRead the full transcript here: https://flot.bio/episode/thomas-clozel-ai-biotech/ 🫶 FOLLOW US- Newsletter: http://eepurl.com/h_fnmH- LinkedIn: https://www.linkedin.com/company/flot-bio/- X (Twitter): https://x.com/FlotBio 🎙️ ABOUT FLOT.BIOFlot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 10k monthly views. Free. ⭐️ SPONSORSHIPReady to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts! 🙏 LIKE/FOLLOW/REVIEWDid you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below. ⏰ TIMESTAMPS[00:00:00] Intro[00:01:26] You need a good pipeline[00:09:24] How Owkin is scaling AI in biotech[00:16:46] Augmenting AI in biotech[00:23:05] How AI can work for small/medium biotech companies[00:27:18] Always looking for more data[00:33:58] Anonymization of data and federated learning[00:42:18] Becoming a biotech company[00:47:29] Small molecules[00:49:10] Limitations[00:51:51] Growing up with billionaire biotech parents[00:56:37] Becoming unfocused and having fun[01:09:02] Getting the best investors[01:18:51] Thanks for listening

In an online special, we’re interviewing Thomas Clozal, the co-founder and CEO of Owkin. We talk about scaling AI in biotech and how it feels to be the child of billionaire biotech parents.💎 ABOUT THE SPEAKERThomas founded Owkin in 2016 and I first met him in 2017. At that time, Owkin was still a baby and I wasn’t sure where it would go. Now it’s a unicorn following a $180M investment from Sanofi in 2021 and has over 300 employees. 🔗 LINKS MENTIONED - Exscientia Expands Biologics Design Capability with Automated Laboratory https://investors.exscientia.ai/press-releases/press-release-details/2022/Exscientia-Expands-Biologics-Design-Capability-with-Automated-Laboratory/default.aspx- Marc de Garidel, Abivax | How to make two billion 💶 exits (kind of smoothly) | E09 https://youtu.be/njZR8udGBTQ- How AI Can Tackle Cancer - Leader in Innovation (Fast Company) https://open.spotify.com/episode/2LQGtAaD7ALSsHslNZJ1mC?si=96a0ba9ddafd4fbc- Aviv Regev leads Genentech's next revolution with AI - https://endpts.com/aviv-regev-leads-genentechs-next-revolution-with-ai/- The 25 Most Valuable Biotech Companies in Europe in 2025: https://flot.bio/most-valuable-biotech-companies-europe-2025/ 📜 TRANSCRIPTRead the full transcript here: https://flot.bio/episode/thomas-clozel-ai-biotech/ 🫶 FOLLOW US- Newsletter: http://eepurl.com/h_fnmH- LinkedIn: https://www.linkedin.com/company/flot-bio/- X (Twitter): https://x.com/FlotBio 🎙️ ABOUT FLOT.BIOFlot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 10k monthly views. Free. ⭐️ SPONSORSHIPReady to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts! 🙏 LIKE/FOLLOW/REVIEWDid you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below. ⏰ TIMESTAMPS[00:00:00] Intro[00:01:26] You need a good pipeline[00:09:24] How Owkin is scaling AI in biotech[00:16:46] Augmenting AI in biotech[00:23:05] How AI can work for small/medium biotech companies[00:27:18] Always looking for more data[00:33:58] Anonymization of data and federated learning[00:42:18] Becoming a biotech company[00:47:29] Small molecules[00:49:10] Limitations[00:51:51] Growing up with billionaire biotech parents[00:56:37] Becoming unfocused and having fun[01:09:02] Getting the best investors[01:18:51] Thanks for listening

NOW PLAYING

Thomas Clozel, Owkin | What does AI Biotech really mean | E10

0:00 1:20:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Flot.bio x Philip Hemme?

This episode is 1 hour and 20 minutes long.

When was this Flot.bio x Philip Hemme episode published?

This episode was published on December 18, 2023.

What is this episode about?

In an online special, we’re interviewing Thomas Clozal, the co-founder and CEO of Owkin. We talk about scaling AI in biotech and how it feels to be the child of billionaire biotech parents.💎 ABOUT THE SPEAKERThomas founded Owkin in 2016 and I first...

Can I download this Flot.bio x Philip Hemme episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!